Grade My Investments
HomeFree Stock Grades › FTRE

Fortrea Holdings Inc. (FTRE) Stock Grade

FTRE · Healthcare

D
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.6B
P/E Ratio
Revenue Growth (YoY)
+1.0%
Net Margin
-36.2%
Return on Equity
Dividend Yield
None

About Fortrea Holdings Inc.'s fundamentals

Fortrea Holdings is a biotechnology company with a market capitalization of $1.6 billion that reported minimal revenue growth of 1.0% year-over-year, indicating a relatively stagnant top line. The company is currently unprofitable, with a net margin of -36.2%, and recorded a net loss in its latest annual statement. Despite the accounting losses, Fortrea generated positive free cash flow, suggesting the business is converting some operational activity into cash despite its negative bottom line. The company does not pay a dividend.

Track FTRE free — no credit card required. Live grade + monthly AI report →